ArticlePrion2026
Early diagnosis of a case of Heidenhain variant of Creutzfeld-Jakob disease by cerebrospinal fluid real-time quaking-induced conversion test.
Article in Prion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare, rapidly progressive, and fatal neurodegenerative disorder caused by the accumulation of abnormal prion proteins in the central nervous system. The Heidenhain variant (HvCJD), a rare subtype of sCJD, is characterized by prominent visual symptoms at onset. Diagnosing sCJD remains challenging due to non-specific clinical presentations and the limited sensitivity and specificity of conventional tests such as magnetic resonance imaging (MRI), electroencephalography (EEG), and cerebrospinal fluid (CSF) 14-3-3 protein analysis. Recently, real-time quaking-induced conversion (RT-QuIC) has emerged as a valuable tool for improving diagnostic accuracy. We present the case of a 65-year-old man who initially experienced blurred vision and diplopia, followed by rapidly progressive dementia and dysuria. Brain MRI revealed cortical diffusion-weighted imaging (DWI) hyperintensities in the right temporo-occipital region. While his CSF 14-3-3 protein test was negative, RT-QuIC assay returned positive, leading to a final diagnosis of probable CJD. The patient died 8 weeks after diagnosis. This case highlights that HvCJD is a rare but important clinical variant in which conventional CSF 14-3-3 testing may be negative, particularly early in the disease course. In contrast, RT-QuIC demonstrates high sensitivity and specificity and can significantly aid in the early and accurate diagnosis of CJD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.